Stay updated with breaking news from Analytical Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Revvity (NYSE:RVTY – Free Report) had its price objective hoisted by KeyCorp from $110.00 to $126.00 in a research note released on Friday morning, Benzinga reports. KeyCorp currently has an overweight rating on the stock. A number of other research analysts also recently commented on the stock. Barclays increased their price objective on shares of […]
Revvity (NYSE:RVTY – Free Report) had its price objective increased by Raymond James from $106.00 to $127.00 in a research note released on Friday morning, Benzinga reports. They currently have an outperform rating on the stock. Several other analysts have also weighed in on RVTY. Barclays boosted their target price on shares of Revvity from […]
Revvity (NYSE:RVTY – Get Free Report) had its price target boosted by analysts at Raymond James from $106.00 to $127.00 in a research report issued on Friday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Raymond James’ price target suggests a potential upside of 18.88% from the stock’s current price. RVTY […]
Revvity (NYSE:RVTY – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $4.55-$4.75 for the period, compared to the consensus estimate of $4.57. The company issued revenue guidance of $2.79-$2.85 billion, compared to the consensus revenue estimate of $2.77 billion. Revvity also updated its FY […]
Revvity (NYSE:RVTY – Get Free Report) and Illumina (NASDAQ:ILMN – Get Free Report) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, profitability, analyst recommendations, institutional ownership, valuation and dividends. Analyst Ratings This is a summary of recent ratings […]